These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1290 related items for PubMed ID: 17093248

  • 21. A retrospective comparison of the efficacy and safety in kidney transplant recipients with basiliximab and anti-thymocyte globulin.
    Wang W, Yin H, Li XB, Hu XP, Yang XY, Liu H, Ren L, Wang Y, Zhang XD.
    Chin Med J (Engl); 2012 Mar; 125(6):1135-40. PubMed ID: 22613543
    [Abstract] [Full Text] [Related]

  • 22. Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation.
    Flaman F, Zieroth S, Rao V, Ross H, Delgado DH.
    J Heart Lung Transplant; 2006 Nov; 25(11):1358-62. PubMed ID: 17097501
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen.
    Yang SL, Wang D, Wu WZ, Lin WH, Xu TZ, Cai JQ, Tan JM.
    Transpl Immunol; 2008 Jan; 18(3):281-5. PubMed ID: 18047938
    [Abstract] [Full Text] [Related]

  • 26. Basiliximab: a review of its use as induction therapy in renal transplantation.
    Chapman TM, Keating GM.
    Drugs; 2003 Jan; 63(24):2803-35. PubMed ID: 14664658
    [Abstract] [Full Text] [Related]

  • 27. Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin.
    Libório AB, Mendoza TR, Esmeraldo RM, Oliveira ML, Paes FJ, Silva Junior GB, Daher EF.
    Int Immunopharmacol; 2011 Nov; 11(11):1832-6. PubMed ID: 21835269
    [Abstract] [Full Text] [Related]

  • 28. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
    Clark G, Walsh G, Deshpande P, Koffman G.
    Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
    [Abstract] [Full Text] [Related]

  • 29. Basiliximab as an alternative to antithymocyte globulin for early immunosuppression in lung transplantation.
    Clinckart F, Bulpa P, Jamart J, Eucher P, Delaunois L, Evrard P.
    Transplant Proc; 2009 Mar; 41(2):607-9. PubMed ID: 19328937
    [Abstract] [Full Text] [Related]

  • 30. Antithymocyte globulin versus basiliximab in renal transplantation.
    Killen JP, Chadban S.
    N Engl J Med; 2007 Feb 08; 356(6):634; author reply 634-5. PubMed ID: 17287486
    [No Abstract] [Full Text] [Related]

  • 31. Rabbit antithymocyte globulin: a postoperative risk factor for sirolimus-treated renal transplant patients?
    Benavides C, Mahmoud KH, Knight R, Barcenas C, Kahan BD, Van Buren CT.
    Transplant Proc; 2005 Mar 08; 37(2):822-6. PubMed ID: 15848544
    [Abstract] [Full Text] [Related]

  • 32. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.
    Nashan B, Moore R, Amlot P, Schmidt AG, Abeywickrama K, Soulillou JP.
    Lancet; 1997 Oct 25; 350(9086):1193-8. PubMed ID: 9652559
    [Abstract] [Full Text] [Related]

  • 33. Effects of Antithymocyte Globulin, Basiliximab, and Induction-Free Treatment in Living Donor Kidney Transplant Recipients on Tacrolimus-Based Immunosuppression.
    Sonmez O, Ozcan SG, Karaca C, Atli Z, Dincer MT, Trabulus S, Seyahi N.
    Exp Clin Transplant; 2024 Apr 25; 22(4):270-276. PubMed ID: 38742317
    [Abstract] [Full Text] [Related]

  • 34. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
    Soulillou JP, Cantarovich D, Le Mauff B, Giral M, Robillard N, Hourmant M, Hirn M, Jacques Y.
    N Engl J Med; 1990 Apr 26; 322(17):1175-82. PubMed ID: 2157982
    [Abstract] [Full Text] [Related]

  • 35. Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids.
    Mourad G, Rostaing L, Legendre C, Garrigue V, Thervet E, Durand D.
    Transplantation; 2004 Aug 27; 78(4):584-90. PubMed ID: 15446319
    [Abstract] [Full Text] [Related]

  • 36. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
    Hill P, Cross NB, Barnett AN, Palmer SC, Webster AC.
    Cochrane Database Syst Rev; 2017 Jan 11; 1(1):CD004759. PubMed ID: 28073178
    [Abstract] [Full Text] [Related]

  • 37. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.
    Kirklin JK, Bourge RC, White-Williams C, Naftel DC, Thomas FT, Thomas JM, Phillips MG.
    J Thorac Cardiovasc Surg; 1990 Apr 11; 99(4):716-24. PubMed ID: 2108282
    [Abstract] [Full Text] [Related]

  • 38. Impact of Cumulative 6 mg/kg Antithymocyte Globulin on Early Posttransplant Outcomes in Kidney Transplant Recipients with Delayed Graft Function.
    Vu VA, Bhayana S, Sweiss H, Castro N, Hall R, Nelson J.
    Prog Transplant; 2024 Jun 11; 34(1-2):47-52. PubMed ID: 38465633
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids.
    Offner G, Toenshoff B, Höcker B, Krauss M, Bulla M, Cochat P, Fehrenbach H, Fischer W, Foulard M, Hoppe B, Hoyer PF, Jungraithmayr TC, Klaus G, Latta K, Leichter H, Mihatsch MJ, Misselwitz J, Montoya C, Müller-Wiefel DE, Neuhaus TJ, Pape L, Querfeld U, Plank C, Schwarke D, Wygoda S, Zimmerhackl LB.
    Transplantation; 2008 Nov 15; 86(9):1241-8. PubMed ID: 19005406
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 65.